GenSight Biologics
SIGHT.PA
#10723
Rank
โ‚ฌ18.39 M
Marketcap
0,07500ย โ‚ฌ
Share price
-1.45%
Change (1 day)
-28.02%
Change (1 year)

EPS for GenSight Biologics (SIGHT.PA)

EPS in 2025: -0,08567ย โ‚ฌ

According to GenSight Biologics's latest financial reports the company's current EPS (TTM) is -0,08567ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,08567ย โ‚ฌ an increase over its 2024 EPS that were of -0,14ย โ‚ฌ.

EPS history for GenSight Biologics from 2013 to 2025

Annual EPS

Year EPS Change
2025-0,08567ย โ‚ฌ-39.79%
2024-0,14ย โ‚ฌ-73.85%
2023-0,54ย โ‚ฌ-7.25%
2022-0,59ย โ‚ฌ-9.79%
2021-0,65ย โ‚ฌ-40.2%
2020-1,09ย โ‚ฌ-2.29%
2019-1,11ย โ‚ฌ-22.09%
2018-1,43ย โ‚ฌ18.75%
2017-1,20ย โ‚ฌ-7.74%
2016-1,30ย โ‚ฌ8.13%
2015-1,21ย โ‚ฌ121.92%
2014-0,54ย โ‚ฌ112.64%
2013-0,26ย โ‚ฌ